Cargando…
Candidate genes of Waldenström’s macroglobulinemia: current evidence and research
Waldenström’s macroglobulinemia (WM) is a relatively uncommon, indolent malignancy of immunoglobulin M-producing B cells. The World Health Organization classifies it as a lymphoplasmacytic lymphoma and patients typically present with anemia, hepatosplenomegaly and diffuse lymphadenopathies. Historic...
Autores principales: | Bianchi, Giada, Sacco, Antonio, Kumar, Shaji, Rossi, Giuseppe, Ghobrial, Irene, Roccaro, Aldo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3735036/ https://www.ncbi.nlm.nih.gov/pubmed/23935380 http://dx.doi.org/10.2147/TACG.S42690 |
Ejemplares similares
-
Role of dual PI3/Akt and mTOR inhibition in Waldenstrom's Macroglobulinemia
por: Sacco, Antonio, et al.
Publicado: (2010) -
Epigenetic modifications as key regulators of Waldenstrom's Macroglobulinemia biology
por: Sacco, Antonio, et al.
Publicado: (2010) -
The importance of the genomic landscape in Waldenström's Macroglobulinemia for targeted therapeutical interventions
por: Sacco, Antonio, et al.
Publicado: (2017) -
Profiling of circulating exosomal miRNAs in patients with Waldenström Macroglobulinemia
por: Bouyssou, Juliette M., et al.
Publicado: (2018) -
Diagnostics in Waldenström’s macroglobulinemia: a consensus statement of the European Consortium for Waldenström’s Macroglobulinemia
por: Dogliotti, Irene, et al.
Publicado: (2022)